Sarcoma growth factor (SGF): Specific binding to epidermal growth factor (EGF) membrane receptors

✍ Scribed by Joseph E. De Larco; George J. Todaro

• Publisher: John Wiley and Sons
• Year: 1980
• Tongue: English
• Weight: 867 KB
• Volume: 102
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/jcp.1041020218

✦ Synopsis

Abstract

Cells transformed by murine sarcoma viruses (MSV) produce and release into their tissue culture media several polypeptide growth stimulating factors. One of these has been partially purified using Bio‐Gel P‐60 column chromatography followed by DEAE‐cellulose chromatography. This growth factor was assigned the name sarcoma growth factor (SGF), and is here shown to require the epidermal growth factor (EGF) receptor in order to function as a growth factor. DEAE‐cellulose chromatography yielded a product that was several‐fold purer than the material present in the Bio‐Gel P‐60 column pool II. The biologically active material from the DEAE‐cellulose column, when labeled with ^125^I, showed specific binding to EGF membrane receptors. The specific binding could be prevented with the addition of either unlabeled EGF or SGF. Both radiolabeled SGF and EGF will bind to live or fixed cells. We were able to bind ^125^I‐SGF as well as ^125^I‐EGF to fixed cells and elute the bound material from fixed receptors. The eluted SGF showed a greater than 25‐fold increase in specific binding. The biological activities of EGF and SGF could be bound to and eluted from fixed cells. A 3T3 clone lacking EGF receptors was unable to respond to either EGF or SGF, whereas it responded well to serum and several other purified growth factors. The SGF isolated using DEAE‐cellulose chromatography was unable to compete in a radioimmune assay using ^125^I‐EGF and antibody to purified mouse submaxillary gland EGF; it also was not precipitated by anti‐EGF antibody.

From these studies it appears that the SGF produced and released by these MSV‐transformed cells combines with and requires the EGF receptor in order to exert its biological effects. The peptide, however, is antigenically distinct from mouse submaxillary gland EGF.